Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jun 11, 2024 12:13am
214 Views
Post# 36082119

RE:RE:RE:Interesting

RE:RE:RE:Interesting
charlierock wrote:
beenthere wrote: Hard to make sense of this for sure!

I have a small position from many years ago of the common.

And I have 30000 shares of the warrants which looks like it's worth zero!

I really don't follow this continuously but in my imo and this is my imo

( don't expect to see any likes of this post)

There is a group of investors here ( a really large group of investors) who fell in love with TLT!

They have lived this stock for more than a decade and have bought year and year!

IF they are lucky and I say IF they are lucky they are at best breaking even but have thousands tied up in this stock!

They cannot let go!  That's what happens when you fall in love with a stock!

So don't fall in love with any stock!

If it's not working  get rid of her!

Better for your heart and your wallet!

Yes don't fall in love with a stock and if it's not working cut your losses. However in TLT's case it is working, better than anything else out there with many other cancer indications on the horizon not to mention very promising early results on the virus research.

When BTD comes the stock price will follow.


Yep...always wise to date the share price before marrying the investment.  This particular one was a keeper imo.

The latest news, while highlighting the achievement of yet another promising preclinical milestone, may ultimately allow us to get a bigger foot in the door of Big Pharma as TLT's tech marries Merck's.  Intimately connecting to a standard of care (i.e. Big Pharma) is a great way to begin a long romance with a wealthy partner.   I hope to see wedding bells in the future...JMO.
<< Previous
Bullboard Posts
Next >>